AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (September 15, 2006). doi:10.1152/ajpheart.00642.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/H503    most recent
00642.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakata, Y.
Right arrow Articles by Mann, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakata, Y.
Right arrow Articles by Mann, D. L.
Submitted on June 15, 2006
Accepted on August 28, 2006

Toll-like Receptor 2 Modulates Left Ventricular Function Following Ischemia-Reperfusion Injury

Yasushi Sakata1, Jian-Wen Dong1, Jesus G Vallejo2, Chien Hua Huang3, Joseph Scott Baker3, Kevin Tracey4, Osamu Takeuchi5, Shizuo Akira5, and Douglas L. Mann6*

1 Medicine, Baylor College of Medicine, Houston, Texas, United States
2 Pediatrics - Infectious Diseases, Baylor College of Medicine, Houston, United States
3 Pediatrics, Baylor College of Medicine, Houston, Texas, United States
4 Surgery, North Shore University Hospital, Manhasset, New York, United States
5 Osaka University, Japan
6 Medicine, Baylor College of Medicine, Houston, United States

* To whom correspondence should be addressed. E-mail: dmann{at}bcm.tmc.edu.

Production of proinflammatory cytokines contributes to cardiac dysfunction during ischemia-reperfusion. The principal mechanism responsible for the induction of this innate stress response during periods of myocardial ischemia-reperfusion remains unknown. Toll-like receptor 2 (TLR2) is a highly conserved pattern recognition receptor that has been implicated in the innate immune response to a variety of pathogens. However, TLR2 may also mediate inflammation in response to non-infectious injury. We therefore hypothesized that TLR2 is essential for modulating myocardial inflammation and left ventricular (LV) function during ischemia-reperfusion injury. Susceptibility to myocardial ischemia-reperfusion injury following ischemia-reperfusion was determined in Langendorff-perfused hearts isolated from wild-type mice and mice deficient in TLR2 (TLR2D) and TIRAP (TIRAP-D). After ischemia-reperfusion, contractile performance was significantly impaired in hearts from wild type mice as demonstrated by a lower recovery of LV developed pressure relative to TLR2D hearts. Creatinine kinase levels were similar in both groups after reperfusion. Contractile dysfunction in wild type hearts was associated with elevated cardiac levels of tumor necrosis factor (TNF) and interleukin-1{beta}. Ischemia-reperfusion induced LV dysfunction was reversed by treatment with the recombinant TNF blocking protein etanercept. These studies show for the first time that TLR2 signaling contributes importantly to the LV dysfunction that occurs following ischemia-reperfusion. Thus, disruption of TLR2 mediated signaling may be helpful to induce immediate or delayed myocardial protection from ischemia-reperfusion injury.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H.-P. Tzeng, J. Fan, J. G. Vallejo, J. W. Dong, X. Chen, S. R. Houser, and D. L. Mann
Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1490 - H1496.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. E. Mullick, K. Soldau, W. B. Kiosses, T. A. Bell III, P. S. Tobias, and L. K. Curtiss
Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events
J. Exp. Med., February 18, 2008; 205(2): 373 - 383.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Favre, P. Musette, V. Douin-Echinard, K. Laude, J.-P. Henry, J.-F. Arnal, C. Thuillez, and V. Richard
Toll-Like Receptors 2-Deficient Mice Are Protected Against Postischemic Coronary Endothelial Dysfunction
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1064 - 1071.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.